Hot off the presses 📰 our @JCOPO_ASCO study shows ctDNA can detect MRD in GCTs, outperforming STMs. Huge multi-center #TeamScience effort—proud of this crew! 💪 @rebeccahassoun @ReubenBenDavid1 @nabiladra @DrJohnSfakianos @TDorffOnc @NateraGenetics
👉ascopubs.org/doi/full/10.12…
👉ascopubs.org/doi/full/10.12…
ascopubs.org Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular... PURPOSESerum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a... 
